, of collaborators form the Jean Verdier Study Group and their affiliations: Erwan Guyot 1,2 , Angela Sutton 1,2 , Valérie Bourcier 3 , Véronique Grando 3 , Marianne Ziol 4,5 , Nathalie Charnaux 1,2 , Michel Beaugrand 3,6 , Pierre Nahon 3,6 , and Nathalie Ganne-Carrié 3, vol.6
,
, University Paris 13-UFR SMBH/INSERM, U1162, Génomique fonctionnelle des Tumeurs solides, CRB des hôpitaux universitaires PSSD, vol.5
, Members of the Swiss Hepatitis C Cohort Study Group, Marc Bourlière (Marseilles), Ioannis Theodorou (Paris)
Evidence-based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma, Gastroenterology, 2016. ,
Hepatocellular carcinoma, N Engl J Med, vol.365, pp.1118-1127, 2011. ,
20-years of population-based cancer registration in hepatitis B and liver cancer prevention in the Gambia, West Africa. PLoS One, vol.8, p.75775, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01261767
Association Between XPD Lys751Gln and Asp312Asn Polymorphisms and Hepatocellular Carcinoma Risk: A Systematic Review And Meta-Analysis, Medicine (Baltimore), vol.93, p.330, 2014. ,
Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs, PLoS One, vol.9, p.84453, 2014. ,
The pathogenesis of hepatocellular carcinoma, Dig Dis, vol.32, pp.545-553, 2014. ,
Hepatitis C virus Core protein overcomes stress-induced premature senescence by downregulating p16 expression via DNA methylation, Cancer Lett, vol.321, pp.154-161, 2012. ,
CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma www.impactjournals.com/oncotarget associated with hepatitis viral infection, Br J Cancer, vol.88, pp.521-529, 2003. ,
Potential role of oxidative DNA damage in the impact of PNPLA3 variant (rs 738409 C>G) in hepatocellular carcinoma risk, Hepatology, vol.60, pp.1110-1111, 2014. ,
Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology, Hepatology, vol.36, pp.1046-1049, 2002. ,
XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis, Liver Int, vol.31, pp.802-809, 2011. ,
Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma, Epidemiology, vol.24, pp.671-681, 2013. ,
hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among Japanese, J Epidemiol, vol.16, pp.233-239, 2006. ,
The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res, vol.36, pp.48-55, 2006. ,
Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population, Mol Cell Biochem, vol.327, pp.7-13, 2009. ,
Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population, Hepatology, vol.52, pp.1301-1309, 2010. ,
Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma, Carcinogenesis, vol.32, pp.530-536, 2011. ,
DNA repair gene XRCC7 polymorphisms (rs#7003908 and rs#10109984) and hepatocellular carcinoma related to AFB1 exposure among Guangxi population, China, Hepatol Res, vol.41, pp.1085-1093, 2011. ,
Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival, J Hepatol, vol.57, pp.621-627, 2012. ,
Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers, Nat Genet, vol.42, pp.755-758, 2010. ,
Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma, Nat Genet, vol.43, pp.455-458, 2011. ,
Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection, PLoS One, vol.6, p.28798, 2011. ,
Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1, Future Oncol, vol.7, pp.253-261, 2011. ,
Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia, Front Genet, vol.5, p.372, 2014. ,
The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations, Proc Natl Acad Sci U S A, vol.101, pp.2357-2362, 2004. ,
BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function, Cell, vol.105, pp.149-160, 2001. ,
FANCM-FAAP24 and FANCJ: FA proteins that metabolize DNA, Mutat Res, vol.668, pp.20-26, 2009. ,
The BRCT domain is a phospho-protein binding domain, Science, vol.302, pp.639-642, 2003. ,
Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass, Oncogene, vol.29, pp.2499-2508, 2010. ,
Mechanistic and biological aspects of helicase action on damaged DNA, Cell Cycle, vol.9, pp.2317-2329, 2010. ,
Fanconi anemia group J helicase and MRE11 nuclease interact to facilitate the DNA damage response, Mol Cell Biol, vol.33, pp.2212-2227, 2013. ,
Cancer in Fanconi anemia, Cancer, vol.97, pp.425-440, 1927. ,
Incidence of liver abnormalities in Fanconi anemia patients, Am J Hematol, vol.87, pp.547-549, 2012. ,
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B www.impactjournals.com/oncotarget virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population, Hepatology, vol.22, pp.432-438, 1995. ,
The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells, EMBO J, vol.26, pp.3238-3249, 2007. ,
Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma, Pathology, vol.42, pp.409-413, 2010. ,
Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients, Am J Surg Pathol, vol.40, pp.770-776, 2016. ,
BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity, Oncol Lett, vol.11, pp.551-558, 2016. ,
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta, Cell, vol.105, pp.587-597, 2001. ,
Genome-wide association studies, PLoS Comput Biol, vol.11, p.1002822, 2012. ,
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer, PLoS Genet, vol.8, p.1002532, 2012. ,
Trans-ethnic genome-wide association studies: advantages and challenges of mapping in diverse populations, Genome Med, vol.6, p.91, 2014. ,
Exegeses on maximum genetic differentiation, Genetics, vol.194, pp.557-559, 2013. ,
Evaluating loci for use in the genetic analysis of population structure, Proceedings of the Royal Society of London B: Biological Sciences, vol.263, pp.1619-1626, 1996. ,
How to interpret a genome-wide association study, JAMA, vol.299, pp.1335-1344, 2008. ,
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data, Hepatology, vol.59, pp.2170-2177, 2014. ,
Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents, Mol Cancer, vol.9, p.127, 2010. ,
Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma, Cancer Chemother Pharmacol, vol.76, pp.1073-1079, 2015. ,
Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy, Biomolecules, vol.2, pp.635-649, 2012. ,
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing, Proc Natl Acad Sci U S A, vol.108, pp.18032-18037, 2011. ,
PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models, BMC Cancer, vol.14, p.603, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01122364
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer, N Engl J Med, vol.373, pp.1697-1708, 2015. ,
Illumina universal bead arrays, Methods Enzymol, vol.410, pp.57-73, 2006. ,
,
, 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes, Nature, vol.491, pp.56-65, 2012.
The structure of haplotype blocks in the human genome, Science, vol.296, pp.2225-2229, 2002. ,
Analysis of multilocus models of association, Genet Epidemiol, vol.25, pp.36-47, 2003. ,
The Interaction of Selection, Linkage. I. General Considerations; Heterotic Models, Genetics, vol.49, pp.49-67, 1964. ,
Fanconi anemia group J mutation abolishes its DNA repair function by uncoupling DNA translocation from helicase activity or disruption of protein-DNA complexes, Blood, vol.116, pp.3780-3791, 2010. ,